Previous Article | Next Article 
Infection and Immunity, April 2001, p. 1994-2000, Vol. 69, No. 4
Department of Laboratory Medicine and Pathobiology,
University of Toronto,1 and Mount Sinai
Hospital and Toronto Medical Laboratories, University Health
Network,2 Toronto, Ontario, Canada, and
Division of Pediatric Infectious Diseases, University of
California, San Diego School of Medicine, La Jolla,
California3
Received 6 July 2000/Returned for modification 3 January
2001/Accepted 8 January 2001
Streptococcus iniae causes meningoencephalitis and
death in commercial fish species and has recently been identified as an emerging human pathogen producing fulminant soft tissue infection. As
identified by pulsed-field gel electrophoresis (PFGE), strains causing
disease in either fish or humans belong to a single clone, whereas
isolates from nondiseased fish are genetically diverse. In this study,
we used in vivo and in vitro models to examine the pathogenicity of
disease-associated isolates. Strains with the clonal
(disease-associated) PFGE profile were found to cause significant
weight loss and bacteremia in a mouse model of subcutaneous infection.
As little as 102 CFU of a disease-associated strain was
sufficient to establish bacteremia, with higher inocula
(107) resulting in increased mortality. In contrast,
non-disease-associated (commensal) strains failed to cause bacteremia
and weight loss, even at inocula of 108 CFU. In addition,
disease-associated strains were more resistant to phagocytic clearance
in a human whole blood killing assay compared to commensal strains,
which were almost entirely eradicated. Disease-associated strains were
also cytotoxic to human endothelial cells as measured by lactate
dehydrogenase release from host cells. However, both disease-associated
and commensal strains adhered to and invaded cultured human epithelial
and endothelial cells equally well. While cellular invasion may still
contribute to the pathogenesis of invasive S. iniae
disease, resistance to phagocytic clearance and direct cytotoxicity
appear to be discriminating virulence attributes of the
disease-associated clone.
Streptococcus iniae is a
hemolytic, gram-positive coccus first isolated in 1976 from a
subcutaneous abscess of a captive freshwater dolphin (27,
28). It causes meningoencephalitis in tilapia, yellowtail,
rainbow trout, and coho salmon (7-9, 18, 19, 29, 34) and
has been associated with disease outbreaks in aquaculture farms, with
mortality rates of up to 50% (8). S. iniae has
more recently been reported to cause fulminant soft tissue infection in
humans (35). Since 1995, 11 cases in Canada of upper limb
cellulitis have been associated with S. iniae infection following percutaneous injury while handling fish. Analysis by pulsed-field gel electrophoresis (PFGE) demonstrated only two, virtually identical, clones (differing by a single band) among strains
capable of causing disease in both humans and fish (21 isolates). In
contrast, isolates from nondiseased fish (32 isolates), as well as the
American Type Culture Collection (ATCC) type strain 29178, were
genetically diverse (35). This suggests that specific, chromosomally encoded virulence determinants may account for the pathogenicity of the clonal (disease-associated) versus
non-disease-associated (commensal) strains.
S. iniae has been well characterized biochemically
(27). However, with regard to potential virulence factors,
no phenotypic differences between disease-associated and commensal
strains have been reported. Data on S. iniae infection in
experimental animals are limited. Early studies reported that rabbits,
guinea pigs, and mice were resistant to subcutaneous, intravenous, and
intraperitoneal injection of 108 CFU of S. iniae
type strain, ATCC 29178 (28). Conversely, disease commonly
observed in fish was reproduced in tilapia following fish-fish passage
of a diseased-fish isolate (8). However, a mammalian model
relevant to human infection had not been established. Since human
disease is characterized by soft tissue infection following skin
puncture, we examined the pathogenicity of representative disease-associated and commensal S. iniae strains in a
murine model of subcutaneous infection. We also used established tissue culture methods to explore potential mechanisms of S. iniae
pathogenicity including resistance to phagocytic clearance, direct
cytotoxicity, and intracellular invasion. This work represents the
first study demonstrating that the unique genetic profile of S. iniae disease-associated isolates correlates with virulence in
experimental model systems.
Bacterial strains, media, and growth conditions.
Strains
used in this study are listed in Table 1.
S. iniae and other gram-positive bacterial strains were
grown in Todd-Hewitt broth (THB) or on Todd-Hewitt agar (THA) or
Columbia base agar (Difco, Detroit, Mich.) supplemented with 5%
defibrinated sheep erythrocytes (Quelab). Overnight cultures were
diluted 1/25 in THB and incubated at 37°C with low agitation. Optical
density at 620 nm was measured over an 8-h period using a Beckman
spectrophotometer (Beckman Instruments, Fullerton, Calif.), and viable
counts were determined. Mid-log phase (108 CFU) was found
to correspond to an optical density at 620 nm of 0.35 to 0.40 for all
strains.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.1994-2000.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Streptococcus iniae Virulence Is
Associated with a Distinct Genetic Profile
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial strains and associated phenotypes
Mouse model. Virulence of S. iniae strains was assessed using a murine model of subcutaneous infection as previously described for Streptococcus pyogenes (group A streptococcus [GAS]) (3). The GAS strain NZ131 was used as a positive control. Mid-log-phase cultures were washed twice in phosphate-buffered saline (PBS) and diluted to the required inoculum (102 to 108 CFU). Bacterial suspensions were mixed with an equal volume of sterilized Cytodex beads (Sigma Laboratories, St. Louis, Mo.) that were suspended in PBS to a concentration of 20 µg/ml. This mixture (200 µl) was injected into the right flanks of five to seven hairless, outbred female SKH1 mice (Charles River Laboratories, Wilmington, Mass.) aged 4 to 5 weeks and weighing 15 to 20 g. Mice were weighed prior to injection and every 24 h for 3 days. Blood and tissue from the injection site were removed from a single mouse at 24 h and from the remaining mice at the end of each trial (72 h). Blood was collected by cardiac puncture and mixed with citrate-buffered saline, and viable counts were determined. The injection site was excised, halved, and weighed following cardiac puncture and euthanization of each animal. For determination of bacterial count, one half of the tissue specimen was placed in 1 ml of PBS and homogenized in a PowerGen 700D homogenizer (Fisher Scientific, Ottawa, Ontario, Canada), and CFU per milligram of tissue was determined. The remaining tissue was immersed in 10% buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin for histologic examination. The experimental procedures performed on the mice were conducted according to the principles of the Animal Care Committee of Mount Sinai Hospital, Toronto, Ontario, Canada.
Phagocytosis assay. Resistance to phagocytosis in whole blood was examined using a modification of the Lancefield bactericidal assay for GAS (20). Mid-log-phase bacteria (108 CFU) were washed and serially diluted in PBS. Bacterial suspensions (100 µl) containing 102 CFU were added to 1 ml of fresh, heparinized human blood in sterile glass tubes and incubated on an orbital shaker for 1.5 h at 37°C. The survival index was calculated as the CFU recovered after the 1.5-h incubation divided by the initial inoculum added prior to incubation. A clinical strain of Staphylococcus epidermidis, 0507, was chosen as a negative control based on the reported susceptibility of this bacterium to whole blood phagocytic killing (6).
LDH release. Lactate dehydrogenase (LDH) release was measured using a Sigma LDH detection kit as previously described (25), with several modifications. Briefly, 10 ml of bacteria (108 CFU/ml) was washed in PBS and resuspended in 1 ml of RPMI 1640 without fetal calf serum (Becton Dickinson, Bedford, Mass.). Human brain microvascular endothelial cell (BMEC) monolayers, grown in a 24-well tissue culture plate (Corning Glass works, Corning, N.Y.), were washed twice in PBS, and 0.5 ml of the above suspension (5.0 × 108 CFU) of S. iniae was added. The group B streptococcus (GBS) strain A909 (5.0 × 107 CFU) was used as a positive control based on its reported cytotoxicity to BMEC monolayers (25) and the association of GBS with meningitis in humans and infrequently with fish (2). The higher inoculum used for S. iniae was required to obtain equivalent results. Plates were incubated for 3 h and then centrifuged to pellet bacteria. Twofold dilutions of each sample were prepared across a 96-well microtiter plate in sterile water, and 20-µl aliquots were transferred to a replica plate. A 100-µl aliquot of 0.1% NADH in standardized pyruvate substrate was added to each well, and the plate was incubated for 30 min at 37°C. Sigma color reagent (100 µl) was then added to each well for 20 min at room temperature. The A450 was used to calculate the residual pyruvic acid activity, which is inversely proportional to the LDH activity. The reciprocal A450 value of the dilution producing 50% LDH release was calculated as a percentage of the total LDH released from complete monolayer lysis.
Adherence and invasion assay. HEp-2 cells were incubated in minimal essential medium (BioWhittaker) supplemented with 6% heat-inactivated fetal calf serum, 200 mM glutamine, and amphotericin B (4 µg/ml) at 37°C in 5% CO2. BMEC were cultured in RPMI 1640 supplemented with 10% fetal calf serum, 10% NuSerum (Becton Dickinson), modified Eagle's medium nonessential amino acids, L-glutamine, and penicillin-streptomycin (26). Twenty-four-well tissue culture plates (Corning) were precoated with rat tail collagen to support BMEC monolayers. Cultures were incubated at 37°C in 5% CO2.
Monolayers of HEp-2 and BMEC were grown to ~80% confluency (~105 cells) in 24-well tissue culture plates and washed three times with PBS, and 500 µl of tissue culture medium was added prior to each assay. Bacterial cultures were washed three times in PBS and resuspended in tissue culture medium without antibiotics. Bacterial inocula of 107 or 105 CFU were added to HEp-2 and BMEC, respectively. HEp-2 cells were incubated for 3 h to allow bacterial adherence and invasion. BMEC plates were centrifuged at 2,000 rpm for 10 min to place bacteria at the surface of the monolayer and incubated for 2 h. To kill extracellular and surface-adherent bacteria, monolayers were washed three times with PBS, followed by the addition of 1 ml of tissue culture medium containing 100 µg of gentamicin and 5 µg of penicillin G to each well and incubation for 2 to 3 h at 37°C. Monolayers were gently washed six times with PBS and, following the addition of 100 µl of trypsin-EDTA, incubated for 10 min at 37°C. A 0.025% solution of Triton X-100 (400 µl) was added, and cells were disrupted by repeated pipetting. Serial dilutions of the resultant lysate were plated onto THA and incubated overnight, and viable counts were determined. To calculate the number of host cell-associated bacteria (total invaded and surface adherent), monolayers were infected as described above, and viable counts were performed without prior exposure to antibiotics. The invasive GBS strain COH1 and the Streptococcus sanguis clinical isolate 2207 served as positive and negative controls, respectively. Invasion or host cell association was determined by the number of the adherent and/or invasive bacteria as a percentage (mean ± standard deviation [SD]) of the original inoculum. Cytochalasin D, an actin microfilament aggregation inhibitor, was used in internalization assays to determine the participation of cytoskeletal elements in bacterial adherence and invasion. HEp-2 monolayers were preincubated with 12.5 to 50.0 ng of cytochalasin D for 30 min before addition of bacteria.| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Mouse model.
Based on our finding that doses greater than
106 CFU of disease-associated strains caused significant
mortality in mice within 24 h, we selected 106 CFU as
the standard infectious dose for this model. Bacteremia developed only
in mice infected with the disease-associated isolates 9116, 9117, and
9033, and as little as 102 CFU (9117) was sufficient to
cause bacteremia within 24 h; lower doses were not tested. Twenty-four
hours following injection of 102 CFU, the bacterial count
in the blood increased to 104 CFU/ml, indicating
significant in vivo replication of disease-associated organisms.
Whether replication occurred at the injection site or in the
bloodstream was not examined. In contrast, commensal strains 9041, 9059, 9066, 9085, and 9098 were not present in the blood of infected
mice after 24 or 72 h at a dose of 106 CFU, and even
at 108 CFU, 9066 was not recovered from blood. Viable
organisms (
103 CFU/mg of tissue) were recovered from the
subcutaneous injection site of mice exposed to both disease-associated
and commensal isolates 24 h following injection. Few (2.0 × 102 CFU/mg of tissue) or no viable organisms were
recovered from injection sites examined 72 h postinjection.
Collectively, these results indicate that bacteremia is associated with
S. iniae strain type (PFGE pattern A/A' [Table 1]) and not
the magnitude of the bacterial inoculum.
3.5 to 6.0 g), 3.5 g (range, 1.5 to 6.5 g), and
2.0 g (range 2.0 to 3.0 g), respectively. In contrast, a weight
gain was observed for those mice injected with sterile Cytodex and no
bacteria (1.5 g; range, 0 to 4.0 g) (P < 0.005;
Wilcoxon signed-rank test) (Fig. 1).
Similarly, weight gain was observed in mice that received 106 CFU of the commensal strains 9041 (1.25 g; range, 0 to
4.0 g), 9059 (1.0 g; range, 0 to 2.5 g), 9066 (0.25 g; range,
0 to 2.5 g), 9085 (2.0 g; range, 1.0 to 4.0 g), and 9098 (1.25 g; range, 0 to 2.0 g). Morbidity, marked by severe lethargy
and wasting, correlated with weight loss in disease-associated
strain-infected animals. In contrast, mice infected with commensal
isolates remained asymptomatic. Examination of
hematoxylin-and-eosin-stained tissue sections from mice injected with
disease-associated or commensal strains did not reveal local tissue
damage or increased polymorphonuclear leukocyte infiltration compared
to tissue sections from control mice that received Cytodex and no
bacteria.
|
Resistance to whole blood killing.
Following exposure of
disease-associated S. iniae strains to human whole blood,
the viable CFU recovered, expressed as percent survival, was slightly
less than the initial inoculum of each strain. As shown in Fig.
2, 84 and 77% of human isolates 9116 and
9117, respectively, and 77% of the fish isolate 9033 were recovered
from blood after 1.5 h of exposure. In contrast, commensal S. iniae strains (9059 and 9066) were rapidly killed by
human whole blood. Survival of isolate 9059 was markedly reduced to 4%
of the initial inoculum, while isolate 9066 was nearly eradicated (0.4%) (Fig. 2).
|
Cellular injury.
To examine potential cytotoxic effects of
S. iniae on host cells, release of a eukaryotic cytoplasmic
enzyme, LDH, from BMEC monolayers exposed to a high inoculum of
bacteria was quantified using a microtiter plate assay. The level of
LDH released was reported as a percentage of the total LDH calculated
from complete lysis of BMEC monolayers. The disease-associated S. iniae strain 9117 (108 CFU) induced LDH release from
BMEC cells (18.26%) similar to a 10-fold-lower inoculum of the
cytolytic GBS strain A909 (18.71%) (Fig.
3). Conversely, the commensal strain 9066 (108 CFU) did not cause a release of LDH above background
levels (medium alone) (Fig. 3).
|
Adherence and invasion.
Representative disease-associated and
commensal strains of S. iniae (9117 and 9085, respectively)
adhered equally to the surface of HEp-2 cells (~105
CFU/ml) from an initial inoculum of 106 cells. Moreover,
each strain invaded HEp-2 cells with an efficiency of 0.1%
(102 CFU/ml) of total cell-associated bacteria. The
negative control, S. sanguis strain 2207, remained
completely noninvasive to HEp-2 cells as expected. The interaction of
S. iniae 9117 with HEp-2 cells was examined by electron
microscopy. Monolayers infected for 2 h with 105 CFU
revealed internalized bacteria clearly enclosed within membrane-bound vesicles (Fig. 4). Dividing forms of
streptococci were also observed. To determine the fate of intracellular
bacteria, viability was assessed 2, 4, 8, 24, and 48 h following
addition of antibiotics to the cell cultures. The number of
internalized bacteria (9117) remained relatively unchanged for 24 h but then declined significantly over the subsequent 24-h period.
Cytochalasin D was used to determine the participation of cytoskeletal
elements in bacterial adherence and invasion. Although bacterial
adherence to HEp-2 cells was not affected, increasing doses of
cytochalasin D quickly abolished invasion of S. iniae (Fig.
5), suggesting that actin microfilaments of the host cytoskeleton were required for internalization of S. iniae.
|
|
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
This is the first report demonstrating differences in virulence between disease-associated and non-disease-associated (commensal) isolates of S. iniae. Our in vivo studies revealed that only disease-associated strains of S. iniae were able to induce weight loss, visible signs of morbidity, and sustained bacteremia in infected mice. In particular, bacteremia was induced at infectious doses as low as 102 CFU. In contrast to human disease, cellulitis at the site of injection was not discernible macroscopically in mice infected with either disease-associated or commensal strains. However, as reported for the majority of human cases (35), bacteremia was evident in mice. Thus, as indicated by bacteremia and weight loss in mice, both of which are restricted to disease-associated strain infections, this model has proven to be useful for studying the virulence of S. iniae. It is interesting that previously reported animal models studying the virulence of the type strain (ATCC 29178), isolated from a dermal lesion of a dolphin, could not establish disease even with high inocula (27). Given the genetic unrelatedness of this strain from the clonal type (35), it would seem that the original S. iniae isolate is not virulent, as defined by the experimental systems used here.
As described, histopathology of mouse tissue sections, following subcutaneous injection of disease-associated strains, did not reveal gross cell damage, yet mice developed persistent bacteremia. This suggested that S. iniae could potentially traverse endothelial cell barriers, gaining direct access to the bloodstream. Our observations clearly indicate that disease-associated strains, whether isolated from humans or diseased fish, are capable of resisting phagocytic activity of human whole blood and that commensal strains are severely limited in this respect. Disease-associated strain survival was marginally reduced, yet commensal strains were nearly abolished. The growth rates of strains tested in bacterial culture media were similar and thus not pertinent to the observed differences in bacterial survival. For several streptococcal pathogens, extracellular polysaccharide capsule (GAS, GBS, Streptococcus pneumoniae, and S. suis) (4, 17, 24, 37) and surface-associated proteins (GAS and type 3 pneumococci) (1, 12) deter phagocytosis and prevent opsonization of bacteria by complement. We have noted that disease-associated strains of S. iniae display a high buoyancy (turbid) in broth culture, whereas commensal strains have a low buoyancy, forming a granular precipitate (unpublished data) as described for the type strain (ATCC 29178) (27). For GBS, buoyancy in broth culture is directly related to the level of capsular polysaccharide expression (15, 16). Furthermore, in an in vivo study, low-buoyancy strains with small amounts of capsule became highly encapsulated and established bacteremia after 5 days of inoculation. Our studies with S. iniae indicate that commensal strains do not cause bacteremia up to 5 days following injection and capsule expression is not evident even in virulent strains (data not shown) (15). Although we have not observed mucoidy in our studies, S. iniae was originally described as an encapsulated organism (27), and mucoid colonies, characteristic of encapsulation, were reported in a fish infection model (8). Furthermore, although M-type surface proteins, which render certain groups of streptococci resistant to phagocytosis, have not been identified in S. iniae, the existence of an uncharacterized surface component or even a secreted factor that might interfere with phagocytosis, as described for SpeB of GAS (22), cannot be excluded.
The ability to induce host cell injury, which is considered a primary step in pathogenesis, has been recognized for several streptococcal pathogens, such as GBS (13, 25) and S. suis type 2 (5). Injury to BMEC monolayers, as determined by the release of LDH, was evident following exposure to the disease-associated S. iniae strain 9117 but not with exposure to the commensal isolate 9066. Damage to endothelial layers could aid bacterial access to the bloodstream and systemic spread, as observed in the murine model. Furthermore, the meningoencephalitis reported in fish disease may be attributed in part to the ability of S. iniae to promote cell injury and disruption of the blood-brain barrier.
Another distinct feature of many streptococcal species, such as GAS, GBS, S. pneumoniae and S. suis (5, 21, 30, 31), is the ability to adhere to host tissue and invade intracellularly where invasion is defined as bacterial internalization within nonphagocytic cells in an in vitro system. Adherence and invasion may bestow resistance to host clearance mechanisms or facilitate systemic dissemination by breaching cell barriers. In this study, we found that both disease-associated and commensal strains could adhere to and invade epithelial and endothelial cells. Internalized bacteria were enclosed within membrane-bound vesicles and were able to survive for considerable lengths of time. GAS and GBS have also been shown to survive intracellularly for long durations without causing damage to the host (14, 31). In our studies, the actin microfilament inhibitor cytochalasin D abrogated invasion, indicating that this process is dependent on host cell cytoskeletal microfilaments as described for pathogens such as GBS, Yersinia enterocolitica, Shigella flexneri, and Escherichia coli (10, 11, 26).
Surprisingly, a reduced adherence and invasion of the disease-associated isolate to BMEC was observed in comparison to the commensal strain, suggesting that the latter was more proficient than the disease-associated strain at invading these cells. However, it should be noted that cellular invasion is not a prerequisite for systemic infections. Highly encapsulated strains of GAS do not invade epithelial cells in vitro, likely due to physical separation of receptor-ligand pairs, yet exhibit an enhanced virulence in vivo (32). The presence of an unidentified surface component in disease-associated strains of S. iniae that could interfere with receptor binding, and perhaps recognition by host phagocytic cells, might explain the lower level of invasion observed.
In summary, we have demonstrated that only S. iniae strains that display the distinct genetic profile associated with clinical disease are virulent in a murine model of subcutaneous infection. This suggests that these clonally related strains express one or more virulence determinants, not present in commensal isolates, which are responsible for systemic infections caused by S. iniae. Both disease-associated and commensal strains adhered to and invaded human epithelial and endothelial cells, indicating that enhanced cellular attachment and intracellular invasion were not discriminating features of disease-associated isolates. In contrast, only disease-associated isolates were resistant to phagocytic clearance and promoted host cell injury, each a phenotypic property that could contribute to virulence of S. iniae. However, in consideration of the direct route of transmission preceding human disease, the antiphagocytic properties of disease-associated strains reported here most likely play a critical role in the pathogenesis of S. iniae infection. Ongoing studies in our laboratory will focus on identifying virulence determinants responsible for the antiphagocytic potential of the disease-associated, clonally related strains of S. iniae.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by a grant from the Canadian Bacterial Diseases Network. J.D.F. is a recipient of a scholarship from the Ontario Graduate Scholarship Programme of the Ministry of Education and Training of Ontario.
We thank Jackie Pittman for assistance with the electron microscopy.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology Rm 1483, Mount Sinai Hospital, 600 University Ave., Toronto, Ontario, Canada M5G 1X5. Phone: (416) 586-8459. Fax: (416) 586-8746. E-mail: jdeazavedo{at}mtsinai.on.ca.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. | Angel, C. S., M. Ruzek, and M. K. Hostetter. 1994. Degradation of C3 by Streptococcus pneumoniae. J. Infect. Dis. 170:600-608[Medline]. |
| 2. | Bercovier, H., C. Ghittino, and A. Eldar. 1997. Immunization with bacterial antigens: infections with streptococci and related organisms. Dev. Biol. Stand. 90:153-160[Medline]. |
| 3. |
Betschel, S. D.,
S. M. Borgia,
N. L. Barg,
D. E. Low, and J. C. De Azavedo.
1998.
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S.
Infect. Immun.
66:1671-1679 |
| 4. |
Brazeau, C.,
M. Gottschalk,
S. Vincelette, and B. Martineau-Doize.
1996.
In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages.
Microbiology
142:1231-1237 |
| 5. |
Charland, N.,
V. Nizet,
C. E. Rubens,
K. S. Kim,
S. Lacouture, and M. Gottschalk.
2000.
Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells.
Infect. Immun.
68:637-643 |
| 6. | DeVoe, I. W., D. W. Storm, and J. E. Gilchrist. 1973. A study of phagocytosis of radio-labeled Staphylococcus epidermidis and on structural events during intracellular degradation. Can. J. Microbiol. 19:525-530[Medline]. |
| 7. | Eldar, A., Y. Bejerano, and H. Bercovier. 1994. Streptococcus shiloi and Streptococcus difficile: two new streptococcal species causing a meningoencephalitis in fish. Curr. Microbiol. 28:193-143[CrossRef]. |
| 8. | Eldar, A., Y. Bejerano, A. Livoff, A. Horovitcz, and H. Bercovier. 1995. Experimental streptococcal meningo-encephalitis in cultured fish. Vet. Microbiol. 43:33-40[CrossRef][Medline]. |
| 9. |
Eldar, A.,
P. F. Frelier,
L. Assenta,
P. W. Varner,
S. Lawhon, and H. Bercovier.
1995.
Streptococcus shiloi, the name for an agent causing septicemic infection in fish, is a junior synonym of Streptococcus iniae.
Int. J. Syst. Bacteriol.
45:840-842 |
| 10. | Finlay, B. B., and S. Falkow. 1988. Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie 70:1089-1099[Medline]. |
| 11. |
Finlay, B. B.,
I. Rosenshine,
M. S. Donnenberg, and J. B. Kaper.
1992.
Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells.
Infect. Immun.
60:2541-2543 |
| 12. |
Fischetti, V. A.
1989.
Streptococcal M protein: molecular design and biological behavior.
Clin. Microbiol. Rev.
2:285-314 |
| 13. | Gibson, R. L., V. Nizet, and C. E. Rubens. 1999. Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr. Res. 45:626-634[Medline]. |
| 14. | Greco, R., L. De Martino, G. Donnarumma, M. P. Conte, L. Seganti, and P. Valenti. 1995. Invasion of cultured human cells by Streptococcus pyogenes. Res. Microbiol. 146:551-560[Medline]. |
| 15. | Hakansson, S., A. M. Bergholm, S. E. Holm, B. Wagner, and M. Wagner. 1988. Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant. Microb. Pathog. 5:345-355[CrossRef][Medline]. |
| 16. | Hakansson, S., and S. Holm. 1986. Influence of polysaccaride capsule and ionic strength on buoyant density of group B streptococci. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 94:139-143[Medline]. |
| 17. | Hostetter, M. K. 1986. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J. Infect. Dis. 153:682-693[Medline]. |
| 18. | Kitao, T., T. Aoki, and R. Sakoh. 1981. Epizootic caused by beta-hemolytic Streptococcus species in cultured freshwater fish. Fish Pathol. 19:173-180. |
| 19. | Kusuda, R. 1992. Bacterial fish diseases in marineculture in Japan with special emphasis on streptococcosis. Isr. J. Aquacult. 44:140. |
| 20. | Lancefield, R. C. 1962. Current knowledge of the type-specifec M antigens of group A streptococci. J. Immunol. 89:307-313. |
| 21. |
LaPenta, D.,
C. Rubens,
E. Chi, and P. P. Cleary.
1994.
Group A streptococci efficiently invade human respiratory epithelial cells.
Proc. Natl. Acad. Sci. USA
91:12115-12119 |
| 22. |
Lukomski, S.,
E. H. Burns, Jr.,
P. R. Wyde,
A. Podbielski,
J. Rurangirwa,
D. K. Moore-Poveda, and J. M. Musser.
1998.
Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs.
Infect. Immun.
66:771-776 |
| 23. |
Madoff, L. C.,
J. L. Michel, and D. L. Kasper.
1991.
A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci.
Infect. Immun.
59:204-210 |
| 24. | Martin, T. R., J. T. Ruzinski, C. E. Rubens, E. Y. Chi, and C. B. Wilson. 1992. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J. Infect. Dis. 165:306-314[Medline]. |
| 25. | Nizet, V., R. L. Gibson, E. Y. Chi, P. E. Framson, M. Hulse, and C. E. Rubens. 1996. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect. Immun. 64:3818-3826[Abstract]. |
| 26. | Nizet, V., K. S. Kim, M. Stins, M. Jonas, E. Y. Chi, D. Nguyen, and C. E. Rubens. 1997. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun. 65:5074-5081[Abstract]. |
| 27. |
Peir, G. B., and S. H. Madin.
1976.
Streptococcus iniae sp. nov., a beta-hemolytic streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis.
Int. J. Syst. Bacteriol.
26:545-553 |
| 28. |
Peir, G. B., and S. H. Madin.
1978.
Isolation and characterization of a second isolate of Streptococcus iniae.
Int. J. Syst. Bacteriol.
28:311-314 |
| 29. | Perera, R. P., S. K. Johnson, M. D. Collins, and D. H. Lewis. 1994. Streptococcus iniae associated with mortality of Tilapia nilotica × T. aurea hybrids. J. Aquat. Anim. Health 6:335-340[CrossRef]. |
| 30. | Ring, A., J. N. Weiser, and E. I. Tuomanen. 1998. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Investig. 102:347-360[Medline]. |
| 31. |
Rubens, C. E.,
S. Smith,
M. Hulse,
E. Y. Chi, and G. van Belle.
1992.
Respiratory epithelial cell invasion by group B streptococci.
Infect. Immun.
60:5157-5163 |
| 32. | Schrager, H. M., J. G. Rheinwald, and M. R. Wessels. 1996. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Investig. 98:1954-1958[Medline]. |
| 33. | Simon, D., and J. J. Ferretti. 1991. Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol. Lett. 66:219-224[Medline]. |
| 34. |
Teixeira, L. M.,
V. L. Merquior,
M. C. Vianni,
M. G. Carvalho,
S. E. Fracalanzza,
A. G. Steigerwalt,
D. J. Brenner, and R. R. Facklam.
1996.
Phenotypic and genotypic characterization of atypical Lactococcus garvieae strains isolated from water buffalos with subclinical mastitis and confirmation of L. garvieae as a senior subjective synonym of Enterococcus seriolicida.
Int. J. Syst. Bacteriol.
46:664-668 |
| 35. |
Weinstein, M. R.,
M. Litt,
D. A. Kertesz,
P. Wyper,
D. Rose,
M. Coulter,
A. McGeer,
R. Facklam,
C. Ostach,
B. M. Willey,
A. Borczyk, and D. E. Low.
1997.
Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group.
N. Engl. J. Med.
337:589-594 |
| 36. | Wessels, M. R., V. J. Benedi, D. L. Kasper, L. M. Heggen, and C. E. Rubens. 1991. Type III capsule and virulence of group B streptococci, p. 219-223. In G. M. Dunny, P. P. Cleary, and L. L. McKay (ed.), Genetics and molecular biology of streptococci, lactococci, and enterococci. American Society for Microbiology, Washington, D.C. |
| 37. |
Whitnack, E.,
A. L. Bisno, and E. H. Beachey.
1981.
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages.
Infect. Immun.
31:985-991 |
Infection and Immunity, April 2001, p. 1994-2000, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.1994-2000.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Eyngor, M., Tekoah, Y., Shapira, R., Hurvitz, A., Zlotkin, A., Lublin, A., Eldar, A.
(2008). Emergence of Novel Streptococcus iniae Exopolysaccharide-Producing Strains following Vaccination with Nonproducing Strains. Appl. Environ. Microbiol.
74: 6892-6897
[Abstract] [Full Text] -
Sun, J.-R., Yan, J.-C., Yeh, C.-Y., Lee, S.-Y., Lu, J.-J.
(2007). Invasive infection with Streptococcus iniae in Taiwan. J Med Microbiol
56: 1246-1249
[Abstract] [Full Text] -
Michel, C., Pelletier, C., Boussaha, M., Douet, D.-G., Lautraite, A., Tailliez, P.
(2007). Diversity of Lactic Acid Bacteria Associated with Fish and the Fish Farm Environment, Established by Amplified rRNA Gene Restriction Analysis. Appl. Environ. Microbiol.
73: 2947-2955
[Abstract] [Full Text] -
Lowe, B. A., Miller, J. D., Neely, M. N.
(2007). Analysis of the Polysaccharide Capsule of the Systemic Pathogen Streptococcus iniae and Its Implications in Virulence. Infect. Immun.
75: 1255-1264
[Abstract] [Full Text] -
Sarropoulou, E., Kotoulas, G., Power, D. M., Geisler, R.
(2005). Gene expression profiling of gilthead sea bream during early development and detection of stress-related genes by the application of cDNA microarray technology. Physiol. Genomics
23: 182-191
[Abstract] [Full Text] -
Miller, J. D., Neely, M. N.
(2005). Large-Scale Screen Highlights the Importance of Capsule for Virulence in the Zoonotic Pathogen Streptococcus iniae. Infect. Immun.
73: 921-934
[Abstract] [Full Text] -
Facklam, R., Elliott, J., Shewmaker, L., Reingold, A.
(2005). Identification and Characterization of Sporadic Isolates of Streptococcus iniae Isolated from Humans. J. Clin. Microbiol.
43: 933-937
[Abstract] [Full Text] -
Zlotkin, A., Chilmonczyk, S., Eyngor, M., Hurvitz, A., Ghittino, C., Eldar, A.
(2003). Trojan Horse Effect: Phagocyte-Mediated Streptococcus iniae Infection of Fish. Infect. Immun.
71: 2318-2325
[Abstract] [Full Text] -
Lau, S. K. P., Woo, P. C. Y., Tse, H., Leung, K.-W., Wong, S. S. Y., Yuen, K.-Y.
(2003). Invasive Streptococcus iniae Infections Outside North America. J. Clin. Microbiol.
41: 1004-1009
[Abstract] [Full Text] -
Cuchacovich, M., Gatica, H., Vial, P., Yovanovich, J., Pizzo, S. V., Gonzalez-Gronow, M.
(2002). Streptokinase Promotes Development of Dipeptidyl Peptidase IV (CD26) Autoantibodies after Fibrinolytic Therapy in Myocardial Infarction Patients. CVI
9: 1253-1259
[Abstract] [Full Text] -
Fuller, J. D., Camus, A. C., Duncan, C. L., Nizet, V., Bast, D. J., Thune, R. L., Low, D. E., de Azavedo, J. C. S.
(2002). Identification of a Streptolysin S-Associated Gene Cluster and Its Role in the Pathogenesis of Streptococcus iniae Disease. Infect. Immun.
70: 5730-5739
[Abstract] [Full Text] -
Neely, M. N., Pfeifer, J. D., Caparon, M.
(2002). Streptococcus-Zebrafish Model of Bacterial Pathogenesis. Infect. Immun.
70: 3904-3914
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»